Starling Oncology, Inc. — Form 8-K
Filed September 1, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 12/100
What the filing says
Starling Oncology filed an 8-K on 2026-09-01 disclosing Item 5.02 events: departure of directors or officers, election of directors, appointment of officers, and compensatory arrangements of certain officers. No specific names, amounts, dates, or transaction details are provided in the accessible filing text — only the item category is listed.
Why this rating
No dollar amounts, share counts, or specific personnel details disclosed. Standard periodic governance filing without quantifiable business impact stated.
Extracted items
See more from September 1, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.